Contact Information
Email: mgbadamosi@ufl.edu
Education
B.Sc, University of Delaware – Newark, DE
Entry date into PTR PhD Program: Fall 2017
Curriculum Vitae
Research Interests
- Pharmacogenomics
- Personalized Medicine
- AML
- Cancer Genomics
- Immunotherapy
- Pediatric Leukemia
Scholarship/Awards
- Graduate School Preeminence Award
- McKnight Graduate Fellowship Affiliate
- Board of Education Summer Fellowship
Professional Memberships
- American Society for Clinical Pharmacology and Therapeutics (ASCPT)
- American Society of Hematology (ASH)
- National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE)
Publications
- Gbadamosi M, Meishinchi S, Lamba JK. Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia. Future Oncology. [In Review].